1、腸道菌群和腫, 10, 111213官腸道菌群和腫, 10, 111213官16, 171. Zitvogel L, Ayyoub M, Routy B, Kroemer G. Microbiome Immunosurveillance.Cell2016;165(2):276-2. WooSR,Corrales16, 171. Zitvogel L, Ayyoub M, Routy B, Kroemer G. Microbiome Immunosurveillance.Cell2016;165(2):276-2. WooSR,CorralesL,GajewskiTF.Innateimmuner

2、ecognitionofcancer.reviewofimmunology2015;33:445-3. WatermanC,CalculL,BeauJ,etal.MiniaturizedCultivationofMicrobiotaAntimalarial Drug Discovery. Medicinalresearchreviews2016; 36(1): 144-2016;535(7610):65-5. SongM,GarrettWS,ChanAT.Nutrients,foods,andcolorectalGastroenterology 2015; 148(6): 1244- 2014

3、;15(3):317-adaN,SeoSU,ChenGY,NunezG.Roleofthegutmicrobiotainimmunityinflammatory disease. Nat Rev Immunol 2013; 13(5): 321-8. IrrazabalT,BelchevaA,GirardinSE,MartinA,PhilpottDJ.Theestinalmicrobiotaincoloncancer.Molecularcell2014;role of 309-9. ZackularJP,RogersMA,Tt,SchlossPD.Thehumangutmicrobiomeas

4、screening tool for colorectal cancer. revRes(Phila)2014;7(11):1112-10.Hickey CA, Kuhn KA, Donermeyer DL, et al. Colitogenic viaOuterMembraneVesicles.CellHostMicrobe2015;17(5):672-11.GreenblumS,TurnbaughPJ,BorensteinE.Metagenomicsystemsbiologyofhuman gut microbiome reveals topological shifts ted with

5、 obesity inflammatoryboweldisease.AcadSciUSA2012;109(2):594-12.ViaudS,SaccheriF,MignotG,etal.estinalinflammatoryboweldisease.AcadSciUSA2012;109(2):594-12.ViaudS,SaccheriF,MignotG,etal.estinalmicrobiotamodulatesancerimmuneeffectsofcyclophosphamide.Science2013;342(6161):971-to therapy by modulating th

6、e tumor microenvironment. Science 2013;967-14.MahoneyKM,RennertPD,FreemanGJ.Combinationcancerimmunotherapyands. NatRevDrugDiscov2015;14(8): 561-15.ReardonDA,GokhalePC,KleinSR,etal.GlioblastomaEradication.CancerImmuneBlockadeinanpetentRes16. ,ZagatoE,BertocchiA,etal.Agut-vascularbarriercontrolsofbacteria.Science2015;350